Skip to main content

The Role of Histamine in Ocular Allergy

  • Chapter
Histamine in Inflammation

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 709))

Abstract

Ocular allergy is a disorder affecting increasing numbers of individuals worldwide. Among the inflammatory mediators that contribute to ocular allergy, histamine is perhaps the best characterized. This monoamine is released by sensitized mast cells upon exposure to allergen and causes symptoms such as redness and tearing. Histamine may also recruit immune cells that can cause long-term damage to ocular surfaces. In this chapter we will discuss the known functions of histamine and histamine receptors in ocular allergy and will describe promising therapies targeting the histamine-signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stahl JL, Barney NP. Ocular allergic disease. Curr Opin Allergy Clin Immunol 2004; 4(5):455–459.

    Article  PubMed  Google Scholar 

  2. Trocme SD, Sra KK. Spectrum of ocular allergy. Curr Opin Allergy Clin Immunol 2002; 2(5):423–427.

    Article  PubMed  Google Scholar 

  3. Leonardi A. The central role of conjunctival mast cells in the pathogenesis of ocular allergy. Curr Allergy Asthma Rep 2002; 2(4):325–331.

    Article  PubMed  Google Scholar 

  4. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008; 88(3):1183–1241.

    Article  PubMed  CAS  Google Scholar 

  5. Bielory L, Ghafoor S. Histamine receptors and the conjunctiva. Curr Opin Allergy Clin Immunol 2005; 5(5):437–440.

    Article  PubMed  CAS  Google Scholar 

  6. Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005; 115(1):118–122.

    Article  PubMed  CAS  Google Scholar 

  7. Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000; 106(6):1019–1032.

    Article  PubMed  CAS  Google Scholar 

  8. Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology 1990; 97(8):992–1000.

    PubMed  CAS  Google Scholar 

  9. Bonini S, Coassin M, Aronni S et al. Vernal keratoconjunctivitis. Eye 2004; 18(4):345–351.

    Article  PubMed  CAS  Google Scholar 

  10. Hoang-Xuan T, Prisant O, Hannouche D et al. Systemic cyclosporine A in severe atopic keratoconjunctivitis. Ophthalmology 1997; 104(8):1300–1305.

    PubMed  CAS  Google Scholar 

  11. Akpek EK, Dart JK, Watson S et al. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 2004; 111(3):476–482.

    Article  PubMed  Google Scholar 

  12. Rikkers SM, Holland GN, Drayton GE et al. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 2003; 135(3):297–302.

    Article  PubMed  CAS  Google Scholar 

  13. Vichyanond P, Tantimongkolsuk C, Dumrongkigchaiporn P et al. Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. J Allergy Clin Immunol 2004; 113(2):355–358.

    Article  PubMed  Google Scholar 

  14. Ormerod AD. Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br J Dermatol 2005; 153(4):701–705.

    Article  PubMed  CAS  Google Scholar 

  15. McGill JI, Holgate ST, Church MK et al. Allergic eye disease mechanisms. Br J Ophthalmol 1998; 82(10):1203–1214.

    Article  PubMed  CAS  Google Scholar 

  16. Cook EB, Stahl JL, Barney NP et al. Ocular mast cells. Characterization in normal and disease states. Clin Rev Allergy Immunol 2001; 20(2):243–268.

    Article  PubMed  CAS  Google Scholar 

  17. Solomon A, Pe’er J, Levi-Schaffer F. Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies. Curr Opin Allergy Clin Immunol 2001; 1(5):477–482.

    PubMed  CAS  Google Scholar 

  18. Bonini S, Bonini S. Pathogenesis of allergic conjunctivitis. In: Denburg J, ed. Allergic Diseases: The New Mechanisms and Therapeutics. New York: Humana Press, Inc.; 1998:509.

    Google Scholar 

  19. Miyazaki D, Nakamura T, Komatsu N et al. Roles of chemokines in ocular allergy and possible therapeutic strategies. Cornea 2004; 23(8 Suppl):S48–S54.

    Article  PubMed  Google Scholar 

  20. Irani AM, Butrus SI, Tabbara KF et al. Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol 1990; 86(1):34–40.

    Article  PubMed  CAS  Google Scholar 

  21. Bielory L. Ocular allergy overview. Immunol Allergy Clin North Am 2008; 28(1):1–23, v.

    Article  PubMed  Google Scholar 

  22. MacDonald SM, Lichtenstein LM. Histamine-releasing factors and heterogeneity of IgE. Springer Semin Immunopathol 1990; 12(4):415–428.

    Article  PubMed  CAS  Google Scholar 

  23. Jutel M, Blaser K, Akdis CA. The role of histamine in regulation of immune responses. Chem Immunol Allergy 2006; 91:174–187.

    Article  PubMed  CAS  Google Scholar 

  24. Leonardi A. Role of histamine in allergic conjunctivitis. Acta Ophthalmol Scand Suppl 2000; 230:18–21.

    Article  PubMed  Google Scholar 

  25. Runswick S, Mitchell T, Davies P et al. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007; 12(6):834–842.

    Article  PubMed  Google Scholar 

  26. Takeuchi K, Kishioka C, Ishinaga H et al. Histamine alters gene expression in cultured human nasal epithelial cells. J Allergy Clin Immunol 2001; 107(2):310–314.

    Article  PubMed  CAS  Google Scholar 

  27. de Boer WI, Sharma HS, Baelemans SM et al. Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can J Physiol Pharmacol 2008; 86(3):105–112.

    Article  PubMed  Google Scholar 

  28. Takahashi T, Ono S, Ogawa K et al. A case of anaphylactoid shock occurring immediately after the initiation of second intravenous administration of high-dose immunoglobulin (IVIg) in a patient with Crow-Fukase syndrome. Rinsho Shinkeigaku 2003; 43(6):350–355.

    PubMed  Google Scholar 

  29. De Dominicis C, Brun P, Motterle L et al. Histamine H1R, H2R, H3R and H4R receptors in normal conjunctiva and in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 2008; 49:E-Abstract 418.

    Google Scholar 

  30. Nakahara H, Izushi K, Sugimoto Y et al. Vascular permeability in allergic conjunctivitis in mice lacking histamine H1 receptors. Eur J Pharmacol 2000; 409(3):313–317.

    Article  PubMed  CAS  Google Scholar 

  31. Izushi K, Nakahara H, Tai N et al. The role of histamine H(1) receptors in late-phase reaction of allergic conjunctivitis. Eur J Pharmacol 2002; 440(1):79–82.

    Article  PubMed  CAS  Google Scholar 

  32. Bayer A, Uludağ HA, Sobaci G et al. Comparison of antiallergic drugs in an experimental model of ocular anaphylaxis. Ophthalmologica 2003; 217(2):119–123.

    Article  PubMed  CAS  Google Scholar 

  33. Papathanassiou M, Giannoulaki V, Tiligada E. Leukotriene antagonists attenuate late phase nitric oxide production during the hypersensitivity response in the conjunctiva. Inflamm Res 2004; 53(8):373–376.

    Article  PubMed  CAS  Google Scholar 

  34. Noble S, McTavish D. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Drugs 1995; 50(6):1032–1049.

    Article  PubMed  CAS  Google Scholar 

  35. Bielory L. Role of antihistamines in ocular allergy. Am J Med 2002; 113Suppl 9A:34S–37S.

    Article  PubMed  CAS  Google Scholar 

  36. Huang JF, Thurmond RL. The new biology of histamine receptors. Curr Allergy Asthma Rep 2008; 8(1):21–27.

    Article  PubMed  CAS  Google Scholar 

  37. Hofstra CL, Desai PJ, Thurmond RL et al. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003; 305(3):1212–1221.

    Article  PubMed  CAS  Google Scholar 

  38. Nakano Y, Takahashi Y, Ono R et al. Role of histamine H(4) receptor in allergic conjunctivitis in mice. Eur J Pharmacol 2009.

    Google Scholar 

  39. Dunford PJ, O’Donnell N, Riley JP et al. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T-cells. J Immunol 2006; 176(11):7062–7070.

    PubMed  CAS  Google Scholar 

  40. Simons FE, Simons KJ. The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 1994; 330(23):1663–1670.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Santa J. Ono .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Landes Bioscience and Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ohbayashi, M., Manzouri, B., Morohoshi, K., Fukuda, K., Ono, S.J. (2010). The Role of Histamine in Ocular Allergy. In: Thurmond, R.L. (eds) Histamine in Inflammation. Advances in Experimental Medicine and Biology, vol 709. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8056-4_5

Download citation

Publish with us

Policies and ethics